Skip to content

Clinical trials

Leukemia, Lymphocytic, Chronic, B-Cell trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Country / region: Hong Kong Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20162
20171
20191
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
AbbVie2
Merck Sharp & Dohme LLC2
Acerta Pharma BV1
The University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell9
Hepatitis B, Chronic1
Leukemia, Myeloid, Acute1
Lymphoma, Follicular1
Lymphoma, Mantle-Cell1
Lymphoma, Non-Hodgkin1
Multiple Myeloma1
Neoplasms1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1
Waldenstrom Macroglobulinemia1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.